Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A

about

Reprogramming towards anabolism impedes degeneration in a preclinical model of retinitis pigmentosa.Toward an elucidation of the molecular genetics of inherited retinal degenerations.

P2860

Q41643467-A2238745-D14D-4FB5-B7C7-EDE98DBBF7ED Q50998111-2448B105-1477-4E0A-9A3A-EF5B0E41F50E

P2860

Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A

Item

http://www.wikidata.org/entity/Q35664199

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A

@ast

Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A

@en

type

Item

label

Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A

@ast

Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A

@en

prefLabel

Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A

@ast

Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A

@en

P1476

Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A

@en

P2093

David S Williams

http://www.w3.org/2001/XMLSchema#string

Vanda S Lopes

http://www.w3.org/2001/XMLSchema#string

P2860

Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps.

Expression in cochlea and retina of myosin VIIa, the gene product defective in Usher syndrome type 1B

Human myosin VIIA responsible for the Usher 1B syndrome: a predicted membrane-associated motor protein expressed in developing sensory epithelia

Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial

Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy

Safety and efficacy of gene transfer for Leber's congenital amaurosis

Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year

Usher syndrome: animal models, retinal function of Usher proteins, and prospects for gene therapy

Structure of MyTH4-FERM domains in myosin VIIa tail bound to cargo

Effect of gene therapy on visual function in Leber's congenital amaurosis

P31

scholarly article

P356

10.1101/CSHPERSPECT.A017319

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25605753

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

4448706

http://www.w3.org/2001/XMLSchema#string

Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A

about

P2860

P2860

Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P921

P932